Upgrade to SI Premium - Free Trial

Mylan (MYL): Raising PT On Copaxone Approval - Wells Fargo

October 4, 2017 7:46 AM
Wells Fargo analyst David Maris, reiterated his Market Perform rating on shares of Mylan (NASDAQ: MYL) and raised the price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles